Activating Macrophage‐Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles
Lang Rao(Shenzhen Metro (China)), Jing Mu(University of California San Diego), Liangcan He(Harbin Institute of Technology), Fei Kang(Xijing Hospital), Shukun Zhao(Wuhan University), Churan Wen(Nanfang Hospital), Zhèn Yáng(National Institutes of Health), Guangyu Yao(Nanfang Hospital), Ni Xie(Xi'an University of Science and Technology), Rui Tian(Beijing Botanical Garden), Yue Sun(Wuhan University), Bo Cai(Union Hospital), Lisen Lin(Fuzhou University), Qian‐Fang Meng(Shenzhen Bay Laboratory)
Cited by 278
Related Papers
Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis
|Nature Communications|2020|373
Multiplexed NIR‐II Probes for Lymph Node‐Invaded Cancer Detection and Imaging‐Guided Surgery
|Advanced Materials|2020|264
Supramolecular Polymerization‐Induced Nanoassemblies for Self‐Augmented Cascade Chemotherapy and Chemodynamic Therapy of Tumor
|Angewandte Chemie International Edition|2021|252
Erythrocyte Membrane-Coated Upconversion Nanoparticles with Minimal Protein Adsorption for Enhanced Tumor Imaging
|ACS Applied Materials & Interfaces|2017|246
SIRT7 antagonizes TGF-β signaling and inhibits breast cancer metastasis
|Nature Communications|2017|229